Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease

Michael F. Shanks, William J. McGeown, Katrina E. Forbes-McKay, Gordon D. Waiter, Mario Ries, Annalena Venneri

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

This functional magnetic resonance imaging (fMRI) study examined changes in brain activation after prolonged (20 weeks) and stabilized treatment with the cholinesterase inhibitor galantamine in a small group of patients with very mild Alzheimer's disease (AD). Two cognitive activation paradigms were chosen: one requiting semantic association and the other relying on attention and requiring target detection. A group of age- and education-matched healthy controls was also scanned for comparison. A modest (but not statistically significant) improvement in behavioral scores after treatment was observed in both fMRI tasks. There were brain activation increases in the semantic association task after treatment, and the differences in brain activation present in the comparison of AD patients' baseline images with those of controls were not detectable after treatment. In the target detection task, regions that were activated in the elderly controls but not in the baseline images of the AD group also showed significant activation after treatment.

Overall, however, the increases were modest and might reflect the heterogeneity of clinical response to treatment in this small group. Future pharmacological fMRI studies should include clinical response as a factor in the analysis of cholinergic enhancement effects in AD patients.

LanguageEnglish
Pages848-859
Number of pages12
JournalJournal of Magnetic Resonance Imaging
Volume25
Issue number6
Early online date18 Apr 2007
DOIs
Publication statusPublished - Jul 2007
EventInternational School on Magnetic Resonance and Brain Function - Erice, Italy
Duration: 21 May 200628 May 2006

Fingerprint

Cholinergic Agents
Brain
Alzheimer Disease
Chemical activation
Target tracking
Magnetic Resonance Imaging
Semantics
Association reactions
Therapeutics
Galantamine
Cholinesterase Inhibitors
Education
Statistical Factor Analysis
Age Groups
Pharmacology

Keywords

  • treatment
  • Alzheimer's disease
  • dementia
  • fMRI
  • imaging
  • galantamine

Cite this

Shanks, Michael F. ; McGeown, William J. ; Forbes-McKay, Katrina E. ; Waiter, Gordon D. ; Ries, Mario ; Venneri, Annalena. / Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. In: Journal of Magnetic Resonance Imaging. 2007 ; Vol. 25, No. 6. pp. 848-859.
@article{82b76f5c806d48319c6790561322ffa7,
title = "Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease",
abstract = "This functional magnetic resonance imaging (fMRI) study examined changes in brain activation after prolonged (20 weeks) and stabilized treatment with the cholinesterase inhibitor galantamine in a small group of patients with very mild Alzheimer's disease (AD). Two cognitive activation paradigms were chosen: one requiting semantic association and the other relying on attention and requiring target detection. A group of age- and education-matched healthy controls was also scanned for comparison. A modest (but not statistically significant) improvement in behavioral scores after treatment was observed in both fMRI tasks. There were brain activation increases in the semantic association task after treatment, and the differences in brain activation present in the comparison of AD patients' baseline images with those of controls were not detectable after treatment. In the target detection task, regions that were activated in the elderly controls but not in the baseline images of the AD group also showed significant activation after treatment. Overall, however, the increases were modest and might reflect the heterogeneity of clinical response to treatment in this small group. Future pharmacological fMRI studies should include clinical response as a factor in the analysis of cholinergic enhancement effects in AD patients.",
keywords = "treatment, Alzheimer's disease, dementia, fMRI, imaging, galantamine",
author = "Shanks, {Michael F.} and McGeown, {William J.} and Forbes-McKay, {Katrina E.} and Waiter, {Gordon D.} and Mario Ries and Annalena Venneri",
year = "2007",
month = "7",
doi = "10.1016/j.mri.2007.02.005",
language = "English",
volume = "25",
pages = "848--859",
journal = "Magnetic Resonance Imaging",
issn = "0730-725X",
number = "6",

}

Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. / Shanks, Michael F.; McGeown, William J.; Forbes-McKay, Katrina E.; Waiter, Gordon D.; Ries, Mario; Venneri, Annalena.

In: Journal of Magnetic Resonance Imaging, Vol. 25, No. 6, 07.2007, p. 848-859.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease

AU - Shanks, Michael F.

AU - McGeown, William J.

AU - Forbes-McKay, Katrina E.

AU - Waiter, Gordon D.

AU - Ries, Mario

AU - Venneri, Annalena

PY - 2007/7

Y1 - 2007/7

N2 - This functional magnetic resonance imaging (fMRI) study examined changes in brain activation after prolonged (20 weeks) and stabilized treatment with the cholinesterase inhibitor galantamine in a small group of patients with very mild Alzheimer's disease (AD). Two cognitive activation paradigms were chosen: one requiting semantic association and the other relying on attention and requiring target detection. A group of age- and education-matched healthy controls was also scanned for comparison. A modest (but not statistically significant) improvement in behavioral scores after treatment was observed in both fMRI tasks. There were brain activation increases in the semantic association task after treatment, and the differences in brain activation present in the comparison of AD patients' baseline images with those of controls were not detectable after treatment. In the target detection task, regions that were activated in the elderly controls but not in the baseline images of the AD group also showed significant activation after treatment. Overall, however, the increases were modest and might reflect the heterogeneity of clinical response to treatment in this small group. Future pharmacological fMRI studies should include clinical response as a factor in the analysis of cholinergic enhancement effects in AD patients.

AB - This functional magnetic resonance imaging (fMRI) study examined changes in brain activation after prolonged (20 weeks) and stabilized treatment with the cholinesterase inhibitor galantamine in a small group of patients with very mild Alzheimer's disease (AD). Two cognitive activation paradigms were chosen: one requiting semantic association and the other relying on attention and requiring target detection. A group of age- and education-matched healthy controls was also scanned for comparison. A modest (but not statistically significant) improvement in behavioral scores after treatment was observed in both fMRI tasks. There were brain activation increases in the semantic association task after treatment, and the differences in brain activation present in the comparison of AD patients' baseline images with those of controls were not detectable after treatment. In the target detection task, regions that were activated in the elderly controls but not in the baseline images of the AD group also showed significant activation after treatment. Overall, however, the increases were modest and might reflect the heterogeneity of clinical response to treatment in this small group. Future pharmacological fMRI studies should include clinical response as a factor in the analysis of cholinergic enhancement effects in AD patients.

KW - treatment

KW - Alzheimer's disease

KW - dementia

KW - fMRI

KW - imaging

KW - galantamine

UR - http://www.journals.elsevier.com/magnetic-resonance-imaging

U2 - 10.1016/j.mri.2007.02.005

DO - 10.1016/j.mri.2007.02.005

M3 - Article

VL - 25

SP - 848

EP - 859

JO - Magnetic Resonance Imaging

T2 - Magnetic Resonance Imaging

JF - Magnetic Resonance Imaging

SN - 0730-725X

IS - 6

ER -